3553 results for «2287»
3553 results
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use
22 May 2025 – From EuroPCR 2025
Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.
Risk stratification of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Welcome to EuroPCR 2025
20 May 2025 – From EuroPCR 2025
Welcome to EuroPCR 2025, the premier event for interventional cardiology innovation and education, where leaders and professionals gather to shape the future of cardiovascular care.
Through decisions in complex left main PCI - Left main restenosis
23 May 2025 – From EuroPCR 2025
Gain comprehensive understanding of left main restenosis mechanisms, diagnostic evaluation, and treatment options. This session includes case presentations with angiographic and intracoronary imaging assessments, explores the role of imaging in management decisions, and reviews therapeutic strategies including repeat stenting, drug-eluting balloons, and coronary artery bypass grafting.
CTO after CABG: complex but feasible
23 May 2025 – From EuroPCR 2025
Overcome the complexities of chronic total occlusion (CTO) PCI after coronary artery bypass grafting (CABG) with this session highlighting real-world challenging cases. Topics include retrograde recanalization via bypass grafts, management of regretted stents, post-CABG intervention challenges, and advanced techniques such as plaque/flap lift-and-shift to optimize procedural...
Essential role of imaging in left main PCI
23 May 2025 – From EuroPCR 2025
Discover the essential role of intravascular imaging, particularly IVUS, in guiding left main PCI. Case studies highlight real-time guidance, management of complex bifurcation lesions, and strategies for stent failure, emphasizing imaging's impact on procedural outcomes.
Contemporary outcomes of PCI patients
22 May 2025 – From EuroPCR 2025
Examine contemporary outcomes in PCI patients through a collection of studies addressing angiographic complication incidences, safety of same-day discharge post-complex PCI, age-related outcome impacts in TAVI patients, and comparative long-term antiplatelet strategies. The session also explores timing effects in routine versus off-hours PCI.
Anatomy, physiology and clinical judgment: insights from contemporary strategies to guide PCI
22 May 2025 – From EuroPCR 2025
Discover contemporary strategies integrating anatomy, physiology, and clinical judgment to guide percutaneous coronary intervention (PCI). This session explores the impact of stress cardiovascular magnetic resonance in primary prevention, viability-guided PCI, and physiology-based decision-making including quantitative flow ratio (QFR). Learn about identifying patients at risk for major...
Updates on percutaneous treatment of pulmonary embolism
22 May 2025 – From EuroPCR 2025
Stay abreast of the latest advances in percutaneous treatment of pulmonary embolism. This session covers clinical outcomes with novel vacuum thrombectomy devices, mechanical thrombectomy registries, catheter-directed therapies in intermediate-high risk PE, and profiles of subacute PE interventions to inform optimal treatment strategies.
DCB in STEMI : why, when and how ?
22 May 2025 – From EuroPCR 2025
Explore the evolving role of drug-coated balloons (DCB) in the management of STEMI patients. This session covers practical approaches including primary PCI with DEB, unconventional solutions in urgent scenarios, and personalized treatment strategies especially in very young patients. Learn how DCB technology intersects with complex lesion...
Management of challenging TAVI device delivery
22 May 2025 – From EuroPCR 2025
Explore innovative solutions for managing challenging TAVI device delivery. This session presents cases involving kinked and stuck Navitor valves, the use of snare devices for retrieval, balloon-expandable TAVI in severe bicuspid aortic stenosis, and alternative access routes such as transaortic access after failed transfemoral valve-in-valve procedures.
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
A central role for cardiac imaging in transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Discover the central role of cardiac imaging in transcatheter left atrial appendage (LAA) closure. This session covers sealing techniques, advances in cardiac tomography for assessing LAA wall thickness, fusion of 3D computational modeling with fluoroscopy guidance, device healing evaluation through early serial imaging, and complex cases...
